20112020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr Mark Ward studied Medicine at Monash University, graduating in 2004. After completing his physician and gastroenterology training at the Alfred Hospital and Eastern Health he undertook an advanced clinical fellowship in London at St. Thomas’ Hospital, where he gained expertise in inflammatory bowel disease and in endoscopy. He was awarded a further degree (Doctor of Medicine) from Monash University in 2017 for research into improving patient outcomes in inflammatory bowel disease. He is the author of multiple publications and is regularly invited to speak on a range of IBD topics at local and national meetings. Mark is currently serving on the Australian Inflammatory Bowel Disease Association Committee.

His focus extends beyond inflammatory bowel disease and irritable bowel syndrome to encompass all aspects of gastroenterology, including coeliac disease, bowel cancer screening and liver disorders. He understands the importance of a multi-disciplinary approach to gastrointestinal disorders, including dietary and psychological based therapies. Mark values communication with patients and families and is committed to providing patient-centred care.

Research area keywords

  • inflammatory bowel disease
  • crohn's disease
  • ulcerative colitis
  • functional gut disorders

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease

Gibson, D. J., Ward, M. G., Rentsch, C., Friedman, A. B., Taylor, K. M., Sparrow, M. P. & Gibson, P. R., Mar 2020, In : Alimentary Pharmacology and Therapeutics. 51, 6, p. 612-628 17 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis

Little, R. D., Chu, I. E., van der Zanden, E. P., Flanagan, E., Bell, S. J., Gibson, P. R., Sparrow, M. P., Shelton, E., Connor, S. J., Roblin, X. & Ward, M. G., 10 Dec 2019, In : Journal of Crohn's and Colitis. 13, 12, p. 1527-1536 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy—early promise but more data needed

Gibson, D. J. & Ward, M. G., Mar 2019, In : Alimentary Pharmacology and Therapeutics. 49, 6, p. 816-817 2 p.

Research output: Contribution to journalEditorialOtherpeer-review

Open Access
1 Citation (Scopus)

Inadequate storage of subcutaneous biological agents by patients with inflammatory bowel disease: Another factor driving loss of response?

Rentsch, C., Headon, B., Ward, M. G. & Gibson, P. R., Jan 2018, In : Journal of Gastroenterology and Hepatology. 33, 1, p. 10-11 2 p.

Research output: Contribution to journalEditorialOtherpeer-review

Open Access

Pharmacist-Led Proactive Therapeutic Drug Monitoring with Infliximab (Proximo): Utility of and Cost Saving Associated with the use of a Rapid Assay for Assessing Drug Level

Rentsch, C., Sparrow, M., Ward, M. G., Friedman, A., Taylor, K. M., Luber, R. P., Su, H. Y., Hopkins, R., Headon, B., Dooley, M. & Gibson, P. R., May 2018, In : Gastroenterology. 154, 6 (Suppl 1), p. S826-S286 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Activities

  • 3 Contribution to workshop, seminar, course

Can we de-escalate biologic therapy in IBD? When and how

Mark Ward (Organiser)

16 Oct 2016

Activity: Participating in or organising an event typesContribution to workshop, seminar, course

Australian Gastroenterology Week - Thioguanine: Is there a role in IBD

Mark Ward (Organiser)

15 Oct 2015

Activity: Participating in or organising an event typesContribution to workshop, seminar, course

Australian Gastroenterology Week - Therapeutic drug monitoring in IBD - Making sense of the data

Mark Ward (Organiser)

13 Oct 2014

Activity: Participating in or organising an event typesContribution to workshop, seminar, course